Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

NovaBridge Biosciences (NBP) Receivables Refunds (2021 - 2023)

NovaBridge Biosciences (NBP) has 3 years of Receivables Refunds data on record, last reported at $652215.2 in Q4 2023.

  • On a quarterly basis, Receivables Refunds fell 43.41% to $652215.2 in Q4 2023 year-over-year; TTM through Dec 2023 was $652215.2, a 43.41% decrease, with the full-year FY2023 number at $661000.0, down 44.36% from a year prior.
  • Receivables Refunds reached $652215.2 in Q4 2023 per NBP's latest filing, down from $1.2 million in the prior quarter.
  • Over the last five years, Receivables Refunds for NBP hit a ceiling of $14.0 million in Q4 2021 and a floor of $652215.2 in Q4 2023.
  • A 3-year average of $5.3 million and a median of $1.2 million in 2022 define the central range for Receivables Refunds.
  • Peak YoY movement for Receivables Refunds: plummeted 91.77% in 2022, then tumbled 43.41% in 2023.
  • Tracing NBP's Receivables Refunds over 3 years: stood at $14.0 million in 2021, then tumbled by 91.77% to $1.2 million in 2022, then plummeted by 43.41% to $652215.2 in 2023.
  • Business Quant data shows Receivables Refunds for NBP at $652215.2 in Q4 2023, $1.2 million in Q4 2022, and $14.0 million in Q4 2021.